Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymectomy in multiple sclerosis: a 3-year follow-up.

J L Trotter, D B Clifford, E B Montgomery

    Neurology
    |July 1, 1985
    PubMed
    Summary

    Thymectomy surgery, with or without azathioprine, showed no benefit for multiple sclerosis (MS) patients after three years. Relapsing-remitting MS patients fared similarly to controls, while chronic progressive MS patients showed worse outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials.

    The journal of prevention of Alzheimer's disease..·2024
    Same author

    Checkpoint therapy for progressive multifocal leukoencephalopathy: pointless?

    European journal of neurology·2020
    Same author

    Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection.

    Molecular neurobiology·2018
    Same author

    Brain morphometric correlates of metabolic variables in HIV: the CHARTER study.

    Journal of neurovirology·2014
    Same author

    Characterizing HIV medication adherence for virologic success among individuals living with HIV/AIDS: Experience with the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) cohort.

    Journal of HIV/AIDS & social services·2014
    Same author

    Selective loss of myelin proteins during autolysis.

    Neurochemical research·2013

    Area of Science:

    • Neurology
    • Immunology
    • Surgical Research

    Background:

    • Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
    • Thymectomy, the surgical removal of the thymus, has been explored as a potential treatment for certain autoimmune conditions.
    • Azathioprine is an immunosuppressive medication often used in managing MS.

    Purpose of the Study:

    • To evaluate the long-term efficacy of thymectomy, with or without azathioprine, in patients with multiple sclerosis.
    • To assess the clinical outcomes of MS patients undergoing thymectomy compared to control groups.

    Main Methods:

    • A cohort of 34 multiple sclerosis patients underwent thymectomy, some receiving concurrent azathioprine therapy for one year.
    • Clinical outcomes were monitored and compared over a three-year follow-up period.

    Related Experiment Videos

  • Patients were stratified into relapsing-remitting and chronic progressive MS groups for analysis.

    • Main Results:

    • No statistically significant evidence of clinical benefit was observed in the overall group of MS patients treated with thymectomy after three years.
    • Relapsing-remitting MS patients in the study group demonstrated comparable or improved clinical status relative to controls.
    • Patients with chronic progressive MS experienced statistically worse clinical outcomes compared to the control group.

    Conclusions:

    • Thymectomy, alone or combined with azathioprine, does not appear to offer a therapeutic benefit for multiple sclerosis patients.
    • The surgical intervention may be associated with poorer outcomes in the chronic progressive form of MS.
    • Further research is warranted to understand the complex interactions between the thymus, immune system, and MS progression.